ADDITIONAL METHODS - UNCATEGORISED

SORT author date clear filters


FILTER RECORDS BY



al-Razi (10th century CE; 4th century AH)
Kitab al-Hawi fi al-tibb [The comprehensive book of medicine]. As cited in Ibn Abī Uṣaybiʿah. ʿUyūn al-anbāʾ fī ṭabaqāt al-aṭibbāʾ [The best accounts of the classes of physicians]. Available in MüIler A, ed. A thirteenth-century history of physicians. 2 vols. Cairo: al-Maṭbaʿah al-Wahbiyyah / Königsberg: Selbstverlag, 1882–4. Vol I, p 314 (five lines from bottom).

View

Aulus Cornelius Celsus (1st century AD)
De Medicina. Florence: Nicolaus [Laurentii]

View

Harvey W (c.1640-1657)
Marginalia. In: Aelius Galenus (1640). ΓΑΛΗΝΟΥ, Πρὸς ΘΡΑΣΥΒΟΥΛΟΝ, περὶ ἀρίστης αἱρέσεως. Galeni, De optima Secta, ad Thrasybulum. In: Goulston DT (editor). Galeni Opuscula hoc Libro comprehensa. London: Richard Badger, pp. 66–143.

View

Boyle R (1661)
In defense of Experimental Essays. In: Certain Physiological Essays, written at distant times, and on several occasions pp 4-5. London: Printed for Henry Herringman at the Anchor in the Lower walk in the New-Exchange.

View

Papin D (1704)
123. Papin an Leibniz. In: Gerland E (1881) Leibnizens und Huygens’ Briefwechsel mit Papin. Berlin:Verlag der Koniglichen Akademie der Wissenschaften. p 328.

View

Ludwig CG (1752)
Commentarii de rebus scientia naturali et medicina gestis [Commentaries on achievements in the natural sciences and medicine] Vol.1, Part 1. Leipzig: Frederick Gleditsch.

View

Duncan A (1773)
Medical and Philosophical Commentaries. Volume First, Part I. London: J Murray.

View

Blane G (1785)
Observations on the diseases incident to seamen. London: Joseph Cooper, pp ix.

View

Warren J (1812)
Remarks on Angina Pectoris. New England Journal Medicine & Surgery 1:1-11.

View

Double FJ (1820)
Considérations thérapeutiques sur une nouvelle préparation de quinquina. Revue médicale, 6ème livraison.

View

de Laplace P-S (1820)
Théorie analytique des probabilités [Analytic theory of probabilities]. Oeuvres complètes 7 (3ème édition). Paris:Courcier, page lxxvii.

View

Elliotson J (1823)
Medical properties of quinine. Medico-Chirurgical Transactions 12:543-564.

View

Thomson TRH (1846)
On the value of quinine in African remittent fever. Lancet 47:244-245.

View

Bryson A (1847)
Report on the Climate and Principal Diseases of the African Station. London: Printed by order of the Lords Commissioners of the Admiralty.

View

Bryson A (1854)
On the prophylactic influence of quinine. Medical Times and Gazette 8:6-7.

View

Schweig G (1854)
Auseinandersetzung der statistischen Methode [Deliberation about the statistical method]. Archiv fὔr physiologische Helkunde 13:305-355.

View

Baikie WB (1856)
Narrative of an exploring voyage up the rivers Kwora and Binue in 1854. London: John Murray.

View

Jürgensen T (1866)
Klinische Studien über die Behandlung des Abdominalytyphus mittelst des kalten wassers [Clinical studes on the treatment of abdominal typhus with cold water]. Leipzig, Vogel, pviii.

View

Fick A (1866)
Die Medicinische Physik [Medical physics]. Braunschweig,Vieweg, pp 430-447.

View

Jessen W (1867)
Zur analytischen statistik [On analytic statistics]. Zeitschrift for biologie 3:128-136.

View

Liebermeister C (1877)
Ueber Wahrscheinlichkeitsrechnung in Anwendung auf therapeutische Statistik [On the calculus of probabilities applied to therapeutic statistics]. In: Volkmann R (ed), Sammlung Klinischer Vortrȁge, Innere Medicin, No 39, pp 935-962.

View

Billings JS (1881)
An Address on our Medical Literature. BMJ 2:262–268.

View

Hartridge G (1886)
Tobacco amblyopia. BMJ 1:200.

View

Stuart W (1889)
A remarkable case of morphine addiction. BMJ 1:1051-52.

View

Anonymous (1890)
The placebo in medicine. Medical Press 1890:18th June p642.

View

Dymock W, Warden CJH, Hooper D (1891)
A history of the principal drugs of vegetable origin met with in British India. Pharmacographia Indica Vol. II. London: Kegan Paul, Trench, Trübner, pp 180-181.

View

Cotton FJ (1899)
The Present Status of the Antistreptococcic Serum. New England Journal of Medicine 140:105-109. DOI: 10.1056/NEJM189902021400501

View

Koch R (1900)
Vierter Bericht über die Thätigkeit der Malaria-Expedition, die Monate März und April 1900 umfassend [Fourth report on the activity of the Malaria Expedition, comprising the months of March and April 1900] Deutsche medicinische Wochenschrift 25:397-398.

View

Choksy NH (1901)
Plague treatment with Lustig’s serum. Indian Medical Gazette 36:154–155.

View

Celli A (1903)
La malaria in Italia durante il 1902. Parte II: Profilassi della malaria. [Malaria in Italy in 1902. Part II: Prophylaxis of Malaria]. Annali di Igiene Sperimentale 13:322-343.

View

Anonymous (1908)
Alcohol in the treatment of pneumonia and enteric fever. Lancet 157:442.

View

Solis-Cohen M, Strickler A (1911)
The effect produced by some therapeutic measures on the different forms of leucocytes in pulmonary tuberculosis. New Enlgand Journal of Medicine 165:563-568.

View

Barnes HL (1912)
Report of 150 cases of pulmonary tuberculosis treated with tuberculin. JAMA 59:332-33.

View

Park WH (1912)
The role of animal experimentation in the discoveries leading to our present knowledge of the etiology, prevention and cure of diphtheria. JAMA 53:453-459.

View

Council on Pharmacy and Chemistry (1913)
Sinkina. JAMA 61:1056-1058.

View

Wesselhoeft W (1915)
Hospital Efficiency from the Standpoint of Hospital Trustees. The New England Journal of Medicine 172:778. 10.1056/NEJM191505271722104

View

Bastedo WA (1915)
Clinical Experience with Liquid Paraffin (Liquid Petrolatum): A Comparative Investigation Made Under the Auspices of the Council on Pharmacy and Chemistry. JAMA 64: 808-809.

View

Goadby K (1916)
An inquiry into the natural history of septic wounds. Lancet 188: 89-95.

View

Mcguire LW, Redden WR (1919)
Treatment of Influenzal pneumonia by the use of convalescent human serum, Second report. JAMA 72:709-713. doi:10.1001/jama.1919.02610100017007

View

Acton HW (1920)
Researches on the treatment of benign tertian fever. Lancet 1:1257-1261.

View

McCall WA (1923)
How to experiment in education. New York: Macmillan.

View

Frost WH (1925)
Rendering account in public health. American Journal of Public Health 15:394-397.

View

Medical Research Council (1925)
Report of the committee upon cinchona derivatives and malaria. In: Clinical comparisons of quinine and quinidine. London: HMSO, pp 5-16.

View

Sinton JA (1926)
Studies in Malaria, with special reference to Treatment. Part I. Introduction and routine methods. Indian Journal of Medical Research 13: 565-577.

View

Sinton JA (1926)
Studies in Malaria, with special reference to treatment. Part II. The effects of treatment on the prevention of relapse in infections with Plasmodium Falciparum. Indian Journal of Medical Research 13: 579-601.

View

Sinton JA (1927)
Studies in Malaria, with special reference to treatment. Part VII. The intravenous injection of sodium stovarsol in the treatment of benign tertian malaria. Indian Journal of Medical Research 15:287-299.

View

Earp JR (1927)
The need for reporting negative results. JAMA 88:119.

View

Sinton JA, Bird W (1929)
Studies in Malaria, with special reference to treatment. Part XI: The Cinchona alkaloids in the treatment of benign tertian malaria. Indian Journal of Medical Research 16: 725-746.

View

King D (1931)
Prevention of post-operative pulmonary complications. Report and Notices of Meetings. The New England Journal of Medicine 205:1320.

View

Walters JE (1932)
Measuring effectiveness of personnel counseling. Personnel Journal, 11, 227-236.

View

Wistar Institute (1934)
Style brief, a guide for authors in preparing manuscripts and drawings for the most effective and economical method of publishing biological research. Philadelphia: The Wistar Institute Press.

View

Mainland D (1934)
Chance and the blood count. Canadian Medical Association Journal 30:656-658.

View

Hicks EP, Diwan Chand S (1935)
The relative clinical efficacy of totaquina and quinine. In: Records of the Malaria Survey of India 5:39-50.

View

Malaria Commission (1937)
The treatment of Malaria: Study of synthetic drugs, as compared with Quinine, in the therapeutics and prophylaxis of Malaria. Bulletin of the Health Organisation, Vol VI, no. 6.

View

Greenwood M (1943)
Statistical note. Lancet 2:634-5.

View

Van Winkle W, Herwick RF, Calvery HO, Smith A (1944)
Laboratory and clinical appraisal on new drugs. Report of the Council on Pharmacy and Chemistry. JAMA 126:958-961.

View

Bransby ER, hunter JW, Magee HE, Milligan EHM, Rodgers TS (1944)
The influence of supplements of vitamins A, B1, B2, C, and D on growth, health and physical fitness. BMJ 1:77.

View

Anderson T (1944)
Clinical studies in sulphonamide chemotherapy. MD thesis, University of Glasgow.

View

Johnstone RDC (1946)
Relapsing benign tertian malaria treated with paludrine. Lancet 2:825-826.

View

Loveless MH (1950)
Milk allergy: a survey of its incidence; experiments with a masked ingestion test. J Allergy 21:489-499.

View

Ross OB (1951)
The use of controls in medical research. JAMA 145:72-75.

View

Powers E, Witmer HL (1951)
An experiment in the prevention of delinquency: the Cambridge-Somerville Youth Study. New York: Columbia University Press.

View

Hammon W, Coriell LL, Stokes J (1952)
Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis: 1. Plan of controlled field tests and results of 1951 pilot study in Utah. JAMA 150:739-749.

View

Mainland D (1954)
The modern method of clinical trial. In Steele JM, ed. Methods in Medical Research, Vol 6. Chicago: Year Book Inc, pp152-158.

View

Rheumatic Fever Working Party of the Medical Research Council of GB and the subcommittee of principal investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. (1955)
Treatment of acute rheumatic fever in children; a co-operative clinical trial of A.C.T.H., Cortisone, and Aspirin. BMJ 1:555-574

View

Mainland D (1955)
An experimental statistician looks at anthropometry. Annals of the New York Academy of Sciences 63:474-483.

View

Cole JO, Ross S, Bouthilet L, Freeman H, Bennett IF, Hoffman JL, Lehmann H (1957)
Recommendations for reporting studies of psychiatric drugs. Public Health Report 72:638–645.

View

Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA (1959)
An Evaluation of Internal-Mammary-Artery Ligation by a Double-Blind Technic. New England Journal of Medicine 260:1115-1118.

View

Mainland D (1960)
The use and misuse of statistics in medical publications. Clinical Pharmacology and Therapeutics 1:411-22.

View

Dimond EG, Kittle CF, Crockett JE (1960)
Comparison of internal mammary artery ligation and sham operation for angina pectoris∗. The American Journal of Cardiology 5:483-486.

View

Glick BS, Margolis R (1962)
A study of the influence of experimental design on clinical outcome in drug research. American Journal of Psychiatry 118:1087-1096.

View

Glick BS (1963)
Inadequacies in the reporting of clinical drug research. Psychiatr Q 37:234-44.

View

Campbell DT, Stanley JC (1963)
Experimental and quasi-experimental designs for research. Chicago: Rand McNally & Company.

View

Mainland D (1963)
The significance of "nonsignificance". Clinical Pharmacology and Therapeutics 4:580-6.

View

Mainland D (1963)
Elementary medical statistics: 2nd edn. Philadelphia: WB Saunders Co.

View

Mahon WA, Daniel EE (1964)
A method for the assessment of reports of drug trials. Canadian Medical Association Journal 90:565-9.

View

Armitage P, Borchgrevink CF (1966)
Prevention of recurrences of myocardial infarction. Comments on a previous article. Archives of Internal Medicine 118:270-274.

View

Pollock TM, Bell JA, Hill AB, Cockburn WC, Cvjetanović B, Evans DG, Kostrzewski J, Schofield FD (1966)
Trials of Prophylactic agents for the control of communicable diseases: a guide to their organization and evaluation‎. Geneva: World Health Organization.

View

Ertl N (1969)
A new way of documenting scientific data from medical publications. Karger Gazette 20:1-4.

View

Doll R (1969)
Recognition of unwanted effects of drugs. BMJ 2:69-76.

View

Garvey WD, Lin N, Nelson CE (1970)
Communication in the physical and social sciences: the process of disseminating and assimilating information differ in these two groups of science. Science 170:1166-1173.

View

Cochrane AL (1972)
Effectiveness and Efficiency: random reflections on health services. London: Nuffield Provincial Hospitals Trust.

View

Medico-Pharmaceutical Forum (1974)
A report by the Forum’s Working Party on Clinical Trials. London: Medico-Pharmaceutical Forum.

View

Davis JM (1975)
Overview: Maintenance therapy in Psychiatry: I. Schizophrenia. American Journal of Psychiatry 132:1237-1244.

View

Rogers SC, Clay PM (1975)
A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illnesses. British Journal of Psychiatry 127:599-603.

View

Davis JM (1976)
Overview: Maintenance therapy in psychiatry:2. Affective disorders. American Journal of Psychiatry 133:1-13.

View

Cornfield J (1976)
Recent methodological contributions to clinical trials. American Journal of Epidemiology 104:408-421.

View

Shaikh W, Vayda E, Freeman W (1976)
A systematic review of the literature on the studies of tonsillectomy and adenoidectomy. Pediatrics 57:401-407.

View

The Association of the British Pharmaceutical Industry (1977)
Guidelines for preclinical and clinical testing of new medicinal products: Part 2 – investigations in man. London: ABPI.

View

The Association of the British Pharmaceutical Industry (1977)
Guidelines for preclinical and clinical testing of new medicinal products: Part 1-Laboratory investigations. London: ABPI.

View

Peto R (1978)
Clinical trial methodology. Biomedicine 28 (special issue):24-36.

View

Cornfield J (1978)
Randomization by group: a formal analysis. American Journal of Epidemiology 108:100-102.

View

White SJ, Freedman LS (1978)
Allocation of patients to treatment groups in a controlled clinical study. British Journal of Cancer 37:849-857.

View

Dudley HAF (1978)
Surgical research: master or servant. The American Journal of Surgery 135:458-460.

View

Waber DP, Vuori-Christiansen L, Ortiz N, Clement JR, Christiansen NE, Mora JO, Reed RB, Herrera MG (1981)
Nutritional supplementation, maternal education, and cognitive development of infants at risk of malnutrition. Am J Clin Nutr (Suppl 4):807-13.

View

Altman DG (1981)
Statistics and ethics in medical research. VIII-Improving the quality of statistics in medical journals. BMJ 282:44–47.

View

Hampton JR (1981)
Presentation and analysis of the results of clinical trials in cardiovascular disease BMJ 282:1371-1373.

View

Thomsen J, Bretlau P, Tos M, Johnsen NJ (1981)
Ménière's disease: endolymphatic sac decompression compared with sham (placebo) decompression. Annals of the New York Academy of Sciences 374:820-30.

View

May GS, Eberlein KA, Furberg CD, Passamani ER, DeMets DL (1982)
Secondary prevention after myocardial infarction: A review of long-term trials. Progress in Cardiovascular Diseases 24:331–352.

View

Chalmers TC (1982)
Combinations of data from randomized control trials. Discussion. Proceedings of Current Topics in Biostatistics and Epidemiology. A memorial symposium in honor of Jerome Cornfield. Biometrics 38:250-3.

View

Altman DG (1982)
Statistics in medical journals. Statistics in Medicine 1:59-71.

View

Altman DG, Gore SM, Gardner MJ, Pocock SJ (1983)
Statistical guidelines for contributors to medical journals. BMJ 286:1489-93.

View

MacLeod IA, Mills PR, MacKenzie JF, Joffe SN, Russell RI, Carter DC (1983)
Neodymium yttrium aluminium garnet laser photocoagulation for major haemorrhage from peptic ulcers and single vessels: a single blind controlled study. BMJ (Clin Res Ed) 286:345.

View

Fleischer D (1985)
Endoscopic Nd: YAG laser therapy for active esophageal variceal bleeding. A randomized controlled study. Gastrointestinal Endoscopy 31:4-9.

View

Freitas D, Donato A, Monteiro JG (1985)
Controlled trial of liquid monopolar electrocoagulation in bleeding peptic ulcers. American Journal of Gastroenterology 80:853-7.

View

Hedges LV, Olkin I (1985)
Statistical methods for meta-analysis. Orlando: Academic Press.

View

Gracely RH, Dubner R, Deeter WR, Wolskee PJ (1985)
Clinicians’ expectations influence placebo analgesia. Lancet 325:43. DOI:https://doi.org/10.1016/S0140-6736(85)90984-5

View

Vartiainen E, Puska P, Tossavainen K, Viri L, Niskanen E, Moisio S, McAlister A, Pallonen U (1986)
Prevention of non-communicable diseases: Risk factors in youth. The North Karelia Youth Project (1984-88). Health Promotion 1:269-83.

View

Schinke SP, Gilchrist LD, Schilling RF, Senechal VA (1986)
Smoking and smokeless tobacco use among adolescents: trends and intervention results. Public Health Reports 101:373-8.

View

Herxheimer A, Zentler-Munro P, Winn D (1986)
Therapeutic trials and society: making the best use of resources. London: Consumers Association.

View

ISIS-1 (first International Study of Infarct Survival) Collaborative Group (1986)
Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2:57-66.

View

Pocock SJ, Hughes MD, Lee RJ (1987)
Statistical problems in the reporting of clinical trials. A survey of three medical journals. New England Journal of Medicine 317:426-32.

View

Roifman CM, Levison H, Gelfand EW (1987)
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 329: 1075–1077.

View

Huth EJ (1987)
Structured abstracts for papers reporting clinical trials. Annals of Internal Medicine 106:626-627.

View

Lindor KD, Hughes RW, Ilstrup DM, Jensen (1987)
Intragastric balloons in comparison with standard therapy for obesity - a randomized, double-blind trial. Mayo Clinic Proceedings 62:992–6.

View

Meshkinpour H, Hsu D, Farivar S (1988)
Effect of gastric bubble as a weight reduction device: a controlled, crossover study. Gastroenterology 95:589–92.

View

Gøtzsche PC (1989)
Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clinical Trials 10:31-56.

View

Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ (1990)
More informative abstracts revisited. Annals of Internal Medicine 113:69-75.

View

Altman DG, Doré CJ (1990)
Randomisation and baseline comparisons in clinical trials. . Lancet 335:149–153.

View

Mathus-Vliegen EM, Tytgat GN, Veldhuyzen-Offermans EA (1990)
Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology 99:362-9.

View

ACP Journal Club (1991)
Supplement to Annals of Internal Medicine. Philadelphia: American College of Physicians, Volume 114, Supplement 1.

View

Advanced Ovarian Cancer Trialists Group (1991)
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. BMJ 303:884-893.

View

Oxman AD, Guyatt GH (1991)
Validation of an index of the quality of review articles. Journal of Clinical Epidemiology 44:121-1278.

View

Ike RW, Arnold WJ, Rothschild EW, Shaw HL, and the Tidal Irrigation Cooperating Group. (1992)
Tidal irrigation versus conservative medical management in patients with osteoarthritis of the knee: a prospective randomized study. Journal of Rheumatology 19:772-9.

View

Milne R, Chambers LW (1993)
Brief Communication: How to read a review article. Health Libraries Review 10:38-39.

View

Milne R, Chambers L (1993)
Assessing the scientific quality of review articles. Journal of Epidemiology and Community Health 47:169-170.

View

Oxman AD, Guyatt GH, Cook DJ, Jaeschke R, Heddle N, Keller J (1993)
An index of scientific quality for health reports in the lay press. Journal of Clinical Epidemiology 46:987-1001.

View

Moher D, Dulberg CS, Wells GA. (1994)
Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 272:122-4.

View

Counsell CE, Clarke MJ, Slattery J, Sandercock PAG (1994)
The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? BMJ 309:1677-1681.

View

Schulz KF, Chalmers I, Grimes DA, Altman DG (1994)
Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 272:125-8.

View

Veterans Affairs Cooperative Variceal Sclerotherapy Group (1994)
Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: results of a randomized, multicenter clinical trial. Hepatology 20:618-25.

View

Hartigan P (1994)
Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: Results of a randomized, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Hepatology 20:618–625.

View

Sutton CJ, Ewen SP, Whitelaw N, Haines P (1994)
Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril 62:696–700.

View

Schulz KF, Chalmers I, Altman DG, Grimes DA, Doré CJ (1995)
The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. Online Journal of Current Clinical Trials 4:197.

View

Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S (1995)
Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clinical Trials 16:62-73.

View

Glasziou P, Irwig M (1995)
An evidence based approach to individualising treatment. BMJ 311:1356.

View

Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS (1996)
Evidence based medicine: what it is and what it isn’t. BMJ 312:71-73.

View

Higgins JPT, Whitehead A (1996)
Borrowing strength from external trials in a meta-analysis. Statistics in Medicine 15:2733-2749.

View

Sutton CJ, Pooley AS, Ewen SP, Haines P (1997)
Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertility and Sterility 68:1070-4.

View

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998)
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613.

View

Jefferson T, Deeks J (1999)
The use of systematic reviews for editorial peer reviewing: a population approach. . In: Godlee F, Jefferson T, eds. Peer review in health sciences. London: BMJ Books, pp 224-234.

View

Yusuf S (2000)
Challenges in the conduct and interpretation of phase II (pilot) randomized trials. . American Heart Journal 139:S136-42.

View

Lewis S, Clarke M (2001)
Forest plots: trying to see the wood and the trees. BMJ 322:1479-80.

View

Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New England Journal of Medicine 344:710–719.

View

Horn J (2001)
Calcium antagonists in Stroke. ISBN 90-9014236-3.

View

Lee WL, Bausell RB, Berman BM (2001)
The growth of health-related meta-analyses published from 1980 to 2000. Evaluation and the Health Professions 24: 327-335.

View

Horn J, Limburg M (2001)
Calcium antagonists for ischemic stroke: a systematic review. Stroke 32:570-6. doi: 10.1161/01.str.32.2.570. PMID: 11157199.

View

Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002)
Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 27:299–309.

View

Lumley T (2002)
Network meta-analysis for indirect treatment comparisons. Statistics in Medicine 21:2313-2324.

View

Clarke M, Alderson P, Chalmers I (2002)
Discussion sections in reports of controlled trials published in general medical journals. JAMA 287: 2799-801.

View

Sandercock P, Roberts I (2002)
Systematic reviews of animal experiments. Lancet 360:586. DOI:https://doi.org/10.1016/S0140-6736(02)09812-4.

View

Psaty BN, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS (2003)
Health outcomes associated with various antihypertensive therapies used as first-line agents - a network meta-analysis. JAMA 289:2534-2544

View

Hopewell S, Clarke M (2003)
How important is the size of a reprint order? International Journal of Technology Assessment in Health Care 19:711-714.

View

Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW and The GRADE Working Group (2004)
Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group. BMC Health Services Research 2004 4:38 doi.org/10.1186/1472-6963-4-38.

View

Carlsson HE, Schapiro SJ, Farah I, Hau J (2004)
Use of primates in research: a global overview. American Journal of Primatology 63:225-37.

View

Pound P, Ebrahim S, Sandercock P, Bracken MB, Roberts I on behalf of the Reviewing Animal Trials Systematically (RATS) Group (2004)
Where is the evidence that animal research benefits humans? BMJ 328:514–7.

View

Bailey J (2005)
Non-human primates in medical research and drug development: a critical review. Biogenic Amines 19:235–255.

View

O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006)
1,026 experimental treatments in acute stroke. Annals of Neurology 59:467-77. https://doi.org/10.1002/ana.20741

View

Weatherall D (2006)
The use of non-human primates in research. A working group report. https://mrc.ukri.org/documents/pdf/the-use-of-non-human-primates-in-research/

View

Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007)
Epidemiology and reporting characteristics of systematic reviews. PLoS Medicine 4(3):e78.

View

Clarke M, Hopewell S, Chalmers I (2007)
Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report. Journal of the Royal Society of Medicine 100: 187-90.

View

Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, Ramasubbu J, Heywood JA (2008)
Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis 9:4-15. DOI: 10.1080/17482960701856300.

View

Matthews RAJ (2008)
Medical progress depends on animal models – doesn’t it? Journal of the Royal Society of Medicine 101: 95–98. DOI 10.1258/jrsm.2007.070164

View

Chalmers I, Milne I, Tröhler U, Vandenbroucke J, Morabia A, Tait G, Dukan E (2008)
The James Lind Library: explaining and illustrating the evolution of fair tests of medical treatments. Journal of the Royal College of Physicians of Edinburgh 38:259-64.

View

Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, Bath PMW, Macleod M, Dirnagl U (2008)
Empirical Evidence of Bias in the Design of Experimental Stroke Studies; A Metaepidemiologic Approach. Stroke 39:929-34. doi: 10.1161/STROKEAHA.107.498725.

View

Greenberg SA (2009)
How citation distortions create unfounded authority: analysis of a citation network. BMJ 339:b2680.

View

Edwards SJ, Clarke MJ, Wordsworth S, Borrill J (2009)
Indirect comparisons of treatments based on systematic reviews of randomised controlled trials. Journal of Clinical Practice 63:841-854.

View

Bastian H, Glasziou P, Chalmers I (2010)
Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Medicine 7:e1000326.

View

Clarke M, Hopewell S, Chalmers I (2010)
Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 376: 20-1.

View

Hooijmans CR, Leenaars M, Ritskes-Hoitinga M (2010)
A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Altern Lab Anim 38:167-82. doi: 10.1177/026119291003800208.

View

Sena ES, van der Worp HB, Bath PMW, Howells DW, Macleod MR (2010)
Publication bias in reports of animal Stroke studies leads to major overstatement of efficacy. PLoS Biol 8(3): e1000344. doi:10.1371/journal.pbio.1000344

View

Riley RD, Lambert PC, Abo-Zaid G (2010)
Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 340:c221.

View

Clarke M, Loudon K (2011)
Effects on patients of their healthcare practitioner's or institution's participation in clinical trials: a systematic review. Trials 12:16.

View

Robinson KA, Goodman SN (2011)
A systematic examination of the citation of prior research in reports of randomized, controlled trials. Annals of Internal Medicine 154(1): 50-55.

View

De Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M (2011)
A search filter for increasing the retrieval of animal studies in Embase. Laboratory Animals 45:268-70.

View

Leenaars M, Ritske-Hoitinga M, Griffin G, Ormandy E. (2011)
Background to the Montréal Declaration on the Synthesis of Evidence to Advance the 3Rs Principles in Science, as Adopted by the 8th World Congress on Alternatives and Animal Use in the Life Sciences, Montréal, Canada, on August 25, 2011. Altex Proceedings, 1/12, Proceedings of WC8.

View

Prinz F, Schlange T, Asadullah K (2011)
Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10:712.

View

Korevaar DA, Hooft L, ter Riet G (2011)
Systematic reviews and meta-analyses of preclinical studies: publication bias in laboratory animal experiments. Laboratory Animals 45: 225–230. DOI: 10.1258/la.2011.010121.

View

Leenaars M, Hooijmans CR, van Veggel N, ter Riet G, Leeflang M, Hooft L, van der Wilt GJ, Tillema A, Ritskes-Hoitinga M (2012)
A step-by-step guide to systematically identify all relevant animal studies. Laboratory Animals 46:24-31.

View

Turner EH, Knoepflmacher D, Shapley L (2012)
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS Med 9(3):e1001189.

View

Goldacre B (2012)
Bad Pharma: how drug companies mislead doctors and harm patients. London: Fourth Estate.

View

Martic-Kehl MI,Schibli R, Schubiger PA (2012)
Can animal data predict human outcome? Problems and pitfalls of translational animal research. European Journal of Nuclear Medicine and Molecular Imaging 39:1492–1496. 10.1007/s00259-012-2175-z

View

Begley CG, Ellis LM (2012)
Raise standards for preclinical cancer research. Nature 483:531.

View

Ioannidis JP (2012)
Extrapolating from animals to humans. Sci Transl Med 4(151):151ps15. doi: 10.1126/scitranslmed.3004631. PMID: 22972841.

View

Clarke M, Hopewell S (2013)
Many reports of randomised trials still don’t begin or end with a systematic review of the relevant evidence. Journal of the Bahrain Medical Society 24: 145-8.

View

Hooijmans CR, Ritskes-Hoitinga M (2013)
Progress in Using Systematic Reviews of Animal Studies to Improve Translational Research. PLoS Med 10(7): e1001482. doi:10.1371/journal.pmed.1001482.

View

De Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M (2013)
Letter to the editor. Updated version of the Embase search filter for animal studies. Laboratory Animals 48:88.

View

Leist M, Hartung T (2013)
Inflammatory findings on species extrapolations: humans are definitely. no 70-kg mice. Archives of Toxicology 87:563–567. doi: 10.1007/s00204-013-1038-0

View

Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E, Howells DW, Salman RA, Macleod MR, Ioannidis JPA (2013)
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol 11: e1001609. doi:10.1371/journal.pbio.1001609.

View

Mueller KF, Briel M, Strech D, Meerpohl JJ, Lang B, Motschall E, Gloy V, Lamontagne F, Bassler D (2014)
Dissemination bias in systematic reviews of animal research: a systematic review. PLoS One 9:e116016. doi: 10.1371/journal.pone.0116016.

View

De Barra M, Erikson K, Strimling P (2014)
How feedback biases give ineffective medical treatments a good reputation. Journal of Medical Internet Research Res 16:e193. doi:10.2196/jmir.3214

View

Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, Wright A, Soumerai SB (2014)
A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. Journal of Clinical Epidemiology 68:324-33.

View

Peers IS, South MC, Ceuppens PR, Bright JD, Pilling E (2014)
Can you trust your animal study data? Nature reviews. Drug discovery. 13. 10.1038/nrd4090-c1.

View

Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, Forbes A (2014)
Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Cochrane Database of Systematic Reviews 2014;(10):MR000035.

View

Boutron I, Altman DG, Hopewell S, Vera-Badillo F, Tannock I, Ravaud P (2014)
Impact of Spin in the Abstracts of Articles Reporting Results of Randomized Controlled Trials in the Field of Cancer: The SPIIN Randomized Controlled Trial. Journal of Clinical Oncology 32:4120-4126.

View

Bafeta A, Trinquart L, Seror R, Ravaud P (2014)
Reporting of results from network meta-analyses: methodological systematic review. BMJ 348:g1741

View

Lee AW (2014)
Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009. Journal of Clinical Epidemiology 67:138–43.

View

Hooijmans CR, IntHout J, Ritskes-Hoitinga M, Rovers MM (2014)
Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare. ILAR J. 55:418-26.

View

Ritskes-Hoitinga M, Leenaars M, Avey M, Rovers M, Scholten R (2014)
Systematic reviews of preclinical animal studies can make significant contributions to health care and more transparent translational medicine. Cochrane Database Syst Rev. 3:ED000078.

View

Pound P, Bracken M (2014)
Is animal research sufficiently evidence based to be a cornerstone of biomedical research? BMJ 348:g3387 doi: 10.1136/bmj.g3387.

View

Sena ES, Currie GL, McCann SK, Macleod MR, Howells DW (2014)
Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. J Cereb Blood Flow Metab 34:737-742. doi:10.1038/jcbfm.2014.28

View

Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, Heneghan C (2014)
The need for randomization in animal trials: an overview of systematic reviews. PLoS One. 2014 Jun 6;9(6):e98856. doi: 10.1371/journal.pone.0098856.

View

Stockwell MS, CaCamargo S, Ramakrishnan R, Holleran S, Findley SE, Kukafka R, Hofstetter AM, Fernandez N, Vawdrey DK (2015)
Registry-linked electronic influenza vaccine provider reminders: a cluster-crossover trial. Pediatrics. 135:e75-82.

View

Altman DG (2015)
Making research articles fit for purpose: structured reporting of key methods and findings. Trials 16:53.

View

Emparanza JI, Cabello JB, Burls AJ. (2015)
Does evidence-based practice improve patient outcomes? An analysis of a natural experiment in a Spanish hospital. Journal of Evaluation in Clinical Practice 21:1059-1065.

View

Green SB (2015)
Can animal data translate to innovations necessary for a new era of patient-centred and individualised healthcare? Bias in preclinical animal research. BMC Medical Ethics 16:53. DOI 10.1186/s12910-015-0043-7.

View

Sackett DL (2015)
Sackett DL. Interview in 2014 and 2015. Brian Haynes, ed. McMaster University.

View

Tricco AC, Antony J, Zarin W, Strifler L, Ghassemi M, Ivory J, Perrier L, Hutton B, Moher D, Straus SE (2015)
A scoping review of rapid review methods. BMC Medicine 13:224. BMC Medicine 13:224.

View

de Vries RBM, Hooijmans CR, Langendam MW, van Luijk J, Leenaars M, Ritskes-Hoitinga M, Wever KE (2015)
A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies. Evidence-based Preclinical Medicine 1, 1, 1–9, e00007, DOI: 10.1002/ebm2.7.

View

Begley CG, Ioannidis JPA (2015)
Reproducibility in Science; Improving the Standard for Basic and Preclinical Research. Circulation Research 116:116–126.

View

Henderson VC, Demko N, Hakala A, MacKinnon N, Federico CA, Fergusson D, Kimmelman J (2015)
A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib. eLife 4:e08351. DOI: 10.7554/eLife.08351.

View

Simmonds M, Stewart G, Stewart L (2015)
A decade of individual participant data meta-analyses: A review of current practice. Contemporary Clinical Trials 45:76-83.

View

Perlman RL (2016)
Mouse models of human disease: An evolutionary perspective. Evol Med Public Health 21:170-6. doi: 10.1093/emph/eow014.

View

Tudur Smith C, Marcucci M, Nolan SJ, Iorio A, Sudell M, Riley R, Rovers MM, Williamson PR (2016)
Individual participant data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No.: MR000007.DOI: 10.1002/14651858.MR000007.pub3.

View

Punja S, Xu D, Schmid CH, Hartling L, Urichuk L, Nikles CJ, Vohra S (2016)
N of 1 trials can be aggregated to generate group mean treatment effects: A systematic review and meta-analysis. Journal of Clinical Epidemiology 76:65-75.

View

Misemer BS, Platts-Mills TF, Jones CW (2016)
Citation bias favoring positive clinical trials of thrombolytics for acute ischemic stroke: a cross-sectional analysis. Trials 17:473.

View

Page MJ, Shamseer L, Altman DG, Tetzlaff J, Sampson M, Tricco AC, Catalá-López F, Li L, Reid EK, Sarkis-Onofre R, Moher D (2016)
Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study. PLoS Medicine 13(5):e1002028.

View

Page MJ, Higgins JPT, Clayton G, Sterne JAC, Hróbjartsson A, Savović J (2016)
Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies. PLOS ONE 11(7):e0159267.

View

Yavchitz A, Ravaud P, Altman DG, Moher D, Hrobjartsson A, Lasserson T, Boutron I (2016)
A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity. Journal of Clinical Epidemiology 75:56-65.

View

Ritskes-Hoitinga M (2016)
Public accountability lecture: World day for animals in laboratories. https://www.ritskes-hoitinga.eu/bestanden/Public%20speech%20Ritskes%20final.pdf

View

Holman C, Piper SK, Grittner U, Diamantaras AA, Kimmelman J, Siegerink B, Dirnagl U (2016)
Where Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and Stroke. PLoS Biol 14(1): e1002331. doi:10.1371/journal.pbio.1002331.

View

Chalmers I (2017)
The evolution of fair tests of treatments over two millennia: a 23 minute audio commentary. Edited by Hamish Chalmers, using unbroadcast recordings made by Freakonomics Radio, with permission.

View

Chiu K, Grundy Q, Bero L (2017)
`Spin' in published biomedical literature: A methodological systematic review. PLoS Biol 15: e2002173.

View

Gurevitch J, Koricheva J, Nakagawa S, Stewart G (2018)
Meta-analysis and the science of research synthesis. Nature 555:175-182. 10.1038/nature25753.

View

Scherer RW, Meerpohl JJ, Pfeifer N, Schmucker C, Schwarzer G, von Elm E (2018)
Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews; (11): MR000005.

View

Ristl R, Urach S, Rosenkranz G, Posch M (2018)
Methods for the analysis of multiple endpoints in small populations: A review. Journal of Biopharmaceutical Statistics 29:1-29.

View

de Vries YA, Roest AM, de Jonge P, Cuijpers P, Munafò MR, Bastiaansen JA (2018)
The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression. Psychological Medicine 48:2453-2455.

View

Cohen D (2018)
Oxford TB vaccine study calls into question selective use of animal data. BMJ 360:j5845 doi: 10.1136/bmj.j5845

View

Hooijmans CR, de Vries RBM, Ritskes-Hoitinga M, Rovers MM, Leeflang MM, IntHout J, Wever KE, Hooft L, de Beer H, Kuijpers T, Macleod MR, Sena ES, ter Riet G, Morgan RL, Thayer KA, Rooney AA, Guyatt GH, Schünemann HJ, Langendam MW, GRADE Working Group (2018)
Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies. PLoS One 13:e0187271. doi: 10.1371/journal.pone.0187271.

View

Pound P, Nicol CJ (2018)
Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions. . PLoS ONE 13(3): e0193758. https://doi.org/10.1371/journal. pone.0193758.

View

Pound P, Ritskes‑Hoitinga M (2018)
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. J Transl Med 16:304 https://doi.org/10.1186/s12967-018-1678-1.

View

Ritskes-Hoitinga M, Wever K (2018)
Improving the conduct, reporting, and appraisal of animal research. BMJ 360:j4935 doi: 10.1136/bmj.j4935.

View

Wieschowski S, Chin WWL, Federico C, Sievers S, Kimmelman J, Strech D (2018)
Preclinical efficacy studies in investigator brochures: Do they enable risk-benefit assessment? PLoS Biol 16:e2004879. https://doi.org/10.1371/journal.pbio.2004879.

View

Marshall IJ, Marshall R, Wallace BC, Brassey J, Thomas J (2019)
Rapid reviews may produce different results to systematic reviews: a meta-epidemiological study. Journal of Clinical Epidemiology 109:30-41.

View

Boutron I, Haneef R, Yavchitz A, Baron G, Novack J, Oransky I, Schwitzer G, Ravaud P (2019)
Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit. BMC Medicine 17;105:1330-1339.

View

Chalmers I, Atkinson P, Badenoch D, Glasziou P, Austvoll-Dahlgren A, Oxman A, Clarke M (2019)
The James Lind Initiative: books, websites and databases to promote critical thinking about treatment claims, 2003 to 2018. Research Involvement and Engagement 5:6. https://doi.org/10.1186/s40900-019-0138-2

View

Leenaars CHC, Kouwenaar C, Stafleu FR, Bleich A, Ritskes-Hoitinga M, de Vries RBM, Meijboom FLB (2019)
Animal to human translation: a systematic scoping review of reported concordance rates. J Transl Med 17:223. https://doi.org/10.1186/s12967-019-1976-2.

View

Ritskes-Hoitinga M, van Luijk J (2019)
How can systematic reviews teach us more about the implementation of the 3Rs and animal welfare? Animals 9:1163.

View

Pound P, Ram R (2020)
Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers. BMJ Open Science 4:e100041. doi:10.1136/bmjos-2019-100041

View

Vollert J, Schenker E, Macleod M, Bespalov A, Wuerbel H, Michel M, Dirnagl U, Potschka H, Waldron AM, Wever K, Steckler T, van de Casteele T, Altevogt B, Sil A, Rice ASC, The EQIPD WP3 study group members (2020)
Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals. BMJ Open Science 4:e100046. doi:10.1136/bmjos-2019-100046

View

Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffrey K, Montgomery A, Rowan K, Juszcak E, Baillie JK, Haynes R, Landray MJ, on behalf of the RECOVERY Collaborative Group (2020)
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRχiv. Doi: https://doi.org/10.1101/2020.06.22.20137273

View

Chalmers I, Abbasi K (2020)
Developing the collaboration between the James Lind Library and the Journal of the Royal Society of Medicine. Journal of the Royal Society of Medicine 113(7):266-9. https://journals.sagepub.com/doi/abs/10.1177/0141076820937539

View

Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse A, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell L, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. doi: https://doi.org/10.1101/2020.07.15.20151852

View

RECOVERY Trial Team (2020)
Randomized Evaluation of COVID019 Therapy (RECOVERY). RECOVERY Central Coordinating Office, Oxford. www.recoverytrial.net

View

Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo AM, García CH, Kieny MP, Malekzadeh R, Murthy S, Preziosi MP, Reddy S, Periago MR, Sathiyamoorthy V, Røttingen JA, Swaminathan S, WHO Solidarity trial consortium (2020)
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. MedRxiv. doi: https://doi.org/10.1101/2020.10.15.20209817

View

Bradley SH, DeVito NJ, Lloyd KE, Richards GC, Rombey T, Wayant C, Gill PJ (2020)
Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps. Journal of the Royal Society of Medicine 113:433-443.

View

Ritskes-Hoitinga M, Leenaars C, Beumer W, Roo TC, Stafleu F, Meijboom FLB (2020)
Improving Translation by Identifying Evidence for More Human-Relevant Preclinical Strategies. Animals 10, 1170; doi:10.3390/ani10071170

View

McCormack JP, Holmes DT (2020)
Your results may vary: the imprecision of medical measurements. BMJ 368:m149 doi: 10.1136/bmj.m149

View

Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Würbel H (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18(7): e3000410. https://doi.org/10.1371/journal.

View

Pound P, Ritskes-Hoitinga M (2020)
Can prospective systematic reviews of animal studies improve clinical translation? J Transl Med 18:15. https://doi.org/10.1186/s12967-019-02205-x

View

Gao Y, Shi S, Li M, Luo X, Liu M, Yang K, Zhang J, Song F, Tian J (2020)
Statistical analyses and quality of individual participant data network meta-analyses were suboptimal: a cross-sectional study. BMC Medicine 18:120.

View

Hamel C, Michaud A. Thuku M, Skidmore B, Stevens A, Nussbaumer-Streit N, Garritty C (2021)
Defining Rapid Reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews. Journal of Clinical Epidemiology 129:74-85.

View

Pérez-Gaxiola G, Verdugo-Paiva F, Rada G, Flórez ID (2021)
Assessment of Duplicate Evidence in Systematic Reviews of Imaging Findings of Children With COVID-19. JAMA Network Open 4(1):e2032690.

View

D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS (2021)
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double- blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Annals of Internal Medicine 124:1019-1030.

View

McLennan S, Nussbaumer-Streit B, Hemkens LG, Briel M (2021)
Barriers and Facilitating Factors for Conducting Systematic Evidence Assessments in Academic Clinical Trials. JAMA Network Open. 4(11):e2136577. url: doi/org/10.1001/jamanetworkopen.2021.36577

View

Langendam MW, Magnuson K, Williams AR, Walker VR, Howdeshell KL, Rooney AA Hooijmans CR (2021)
Developing a database of systematic reviews of animal studies. Regulatory Toxicology and Pharmacology Vol 123 (2021) 104940.

View

Menon JML, Ritskes-Hoitinga M, Pound P, van Oort E (2021)
The impact of conducting preclinical systematic reviews on researchers and their research: A mixed method case study. PLoS ONE 16(12): e0260619. ttps://doi.org/10.1371/ journal.pone.0260619.

View

Dirven H, Vist GE, Bandhakavi S, Mehta J, Fitch SE, Pound P, Ram R, Kincaid B, Leenaars CHC, Chen M, Wright RA, Tsaioun K (2021)
Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review. Sci Rep 11:6403. doi: 10.1038/s41598-021-85708-2.

View

Nørgaard B, Draborg E, Andreasen J, Juhl CB, Yost J, Brunnhuber K, Robinson KA, Lund H (2022)
Systematic reviews are rarely used to inform study design - a systematic review and meta-analysis. Journal of Clinical Epidemiology 145: 1-13.

View

Clarke M (2015).
History of evidence synthesis to assess treatment effects: personal reflections on something that is very much alive. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Wager E (2015).
Good Publication Practice 3: reflections on becoming a guideline grandmother. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Altman DG†, Simera I (2015).
A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. JLL Bulletin: Commentaries on the history of treatment evaluation.

View